Ask us a question 520 547-3440 info@c-path.org

Subscribe

Home
About
Programs
Sharing Knowledge that Leads to Innovation
ACTIVE CONSORTIA / PROGRAMS

BmDR

Biomarker Data Repository

MSOAC

Multiple Sclerosis Outcome Assessments Consortium

CPA-1

Critical Path for Alpha-1 Antitrypsin Deficiency

PRO Consortium

Patient-Reported Outcome Consortium

CPAD

Critical Path for Alzheimer’s Disease

PKDOC

Polycystic Kidney Disease Outcomes Consortium

CPLD

Critical Path for Lysosomal Diseases Consortium

PredicTox KE

PredicTox Knowledge Environment

CPP

Critical Path for Parkinson’s

PSTC

Predictive Safety Testing Consortium

CP-RND

Critical Path for Rare Neurodegenerative Diseases

QuantMed

Quantitative Medicine Program

CP-SCD

Critical Path for Sickle Cell Disease

RDCA-DAP

Rare Disease Cures Accelerator-Data and Analytics Platform

CPTA

Critical Path to Therapeutics for the Ataxias

RD-COA Consortium

Rare Disease Clinical Outcome Assessment Consortium

CDRC

CURE Drug Repurposing Collaboratory

RegSci

Regulatory Science Program

DCC

Data Collaboration Center

TB-PACTS

TB-Platform for Aggregation of Clinical TB Studies

D-RSC

Duchenne Regulatory Science Consortium

TTC

Transplant Therapeutics Consortium

eCOA Consortium

Electronic Clinical Outcome Assessment Consortium

TOMI-T1D

Trial Outcome Markers Initiative in T1D Consortium

FA-ICD

Friedreich’s Ataxia Integrated Clinical Database

TRxA

Translational Therapeutics Accelerator

HD-RSC

Huntington’s Disease Regulatory Science Consortium

T1D

Type 1 Diabetes Consortium

INC

International Neonatal Consortium

Completed Consortia

CFAST

Coalition for Accelerating Standards & Therapies

PTC

Pediatric Trials Consortium

CPTR

Critical Path to TB Drug Regimens
C-Path in Europe
Tools & Platforms
Impact
Training
- MIDD Training Course
- Graduate Certificate in RegSci
News & Events
- Events
- News
- Videos
- Publications
- Presentations
- Press Releases
Make a Gift

News

Home>News & Events>Publications>D-RSC>Finding Routes to Duchenne Drug Approvals

144

Publications

February 20, 2016 PRINT PDF

Finding Routes to Duchenne Drug Approvals

Related Posts

226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
PPMD blogs about D-RSC Annual Meeting
Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
D-RSC Definitions

Annual Reports
Contact
Make a Gift
Employment
Explore C-Path
FAQs
FDA Acknowledgement
Policies
GDPR SCCs
Privacy Policy
Terms of Use

C-Path Main Office 1840 E River Rd, Suite 100
Tucson, AZ. 85718
Tel: 520-547-3440
Fax: 520-547-3456 C-Path Amsterdam Barbara Strozzilaan 201
1083 HN Amsterdam, Netherlands
(By Appointment Only)

Ask us a question Tel: 520-547¬3440
Email: info@c-path.org Subscribe

x

Contact Us

Name

Email

Phone

Message

Contact Us

Name

Email

Phone

Message

Contact Us

Name

Email

Phone

Message